VIVA Biotech Holdings

Overview

Collaboration CRO in Preclinical Drug Discovery\\Based in Shanghai, China Viva Biotech is one of the few biology-focused CROs providing preclinical drug discovery research services.\\Viva is privately owned and financed by leading investors in the US. It currently employs close to 200 scientists at a 65,000 sq. ft. research center. The center is equipped with state-of-the-art instruments housed by modern laboratories in an artistically designed building. Viva now works with most of the top ten largest global pharmaceutical companies and dozens of small to medium sized US and Europe-based businesses in studies of gene-to-structure, reagent provision, in vitro and in vivo assays, target ID, ADME, animal models, and more.\\Dating back to 2006, Viva's team has been known for pioneering structural biology services. Viva's experience, track record, and number of project teams focused in protein science are unmatched by any other company in China. By building on this strength, Viva is determined to increase the existing service model, build additional project teams with the same scientific rigor and quality, and expand into other challenging disciplines that play key roles in drug discovery research. Viva is keen on improving its technology and expertise while distinguishing itself from large chemistry-focused CROs.